ASTRAZENECA has paid $250m for the rights to develop an antibody that could help in the fight against cancer.
The pharmaceutical firm’s research and development arm MedImmune, which is based in Cambridge, has entered into an agreement with Innate Pharma that will allow it exclusive access to the company’s anti-NKG2A antibody.
Real estate firms, which have traditionally been slow to innovate, are beginning to embrace new technologies to find clever solutions to old problems. This newfound openness comes as millennials start to enter the workforce, creating a need for tools that appeal to a tech-savvy customer base.
“It’s pretty fascinating when you think about we’re 75 percent millennials in maybe a dozen years. Clearly technology’s going to have an incredibly important impact on real estate; the operation of real estate and what the tenants do and how they do it,” said Joel Marcus, the CEO of Alexandria Real Estate Properties, an REIT that specializes in science campuses.
Among this year’s Mentors-in-Residence at Johns Hopkins Technology Ventures are a senior-level biomedical executive, a chief executive at a company developing novel treatments for neurodegenerative diseases, a two-time medical device industry Most Valuable Thought Leader and an American Pain Foundation chairperson.
These are just four of the 14 entrepreneurial leaders serving at Johns Hopkins as Mentors-in-Residence in 2015, the second year of the program. All 14 mentors this year are business leaders, entrepreneurs and development-driven experts with a passion for innovation and growth.
Since 2003, the Johns Hopkins Alliance for Science and Technology Development has brought faculty members and investors together for an annual daylong meeting to foster important biotechnical and pharmaceutical developments.
This year, 14 faculty members or teams of faculty members from The Johns Hopkins University and seven from the University of Maryland, Baltimore, presented work, as did eight startups affiliated with each university. Four Johns Hopkins University researchers received monetary awards for translational development of their inventions at the April 20 annual joint meeting of the alliance and the University of Maryland, Baltimore’s Commercial Advisory Board.
United States-based New Enterprise Associates (NEA), which last week raised $3.1 billion in the world’s largest venture capital fund, is looking to step up investments in India after going slow over the past two-three years. The venture capital fund, which has backed start-ups such as daily deals firm Groupon and online storage service Box in the US, has said that it will look to sharpen its focus on technology related themes.
Wed, May 6, 2015 2:00 PM – 3:00 PM EDT
This is an educational webinar on the NHLBI Phase IIB Bridge and Small Market funding opportunities to support continued development of SBIR/STTR Phase II projects focused on heart, lung, blood, or sleep technologies. The Small Market Awards support projects focused on rare diseases or for pediatric indications.
Phase IIB Bridge RFA-HL-16-009: http://1.usa.gov/1Deb9h5 Phase IIB Small Market RFA-HL-14-012: http://1.usa.gov/1p2cvbi
Presenters: Jennifer Shieh, PhD – NHLBI Small Business Coordinator Gary Robinson, PhD – NHLBI Business Development Advisor
The University of Maryland (UMD) and MakerBot, a global leader in the desktop 3D printing industry, will be holding a grand opening of the new MakerBot Innovation Center at UMD on April 23, 2015. UMD is the first in the Big Ten, and the first in the Baltimore-Washington Metropolitan area, to launch a MakerBot Innovation Center – a large-scale 3D printing installation that is designed to empower university faculty, students and organizations to innovate faster, increase collaboration and compete more effectively. Grand opening festivities will begin at 2:00 p.m., Thursday, April 23, at the University of Maryland, Technology Advancement Program Building, 387 Technology Drive, College Park, Maryland, with speeches from university staff and representatives from MakerBot.
Virginia will create a new online portal where researchers can post information about their biotech projects — information employers can then use for recruitment and investment opportunities, Gov. Terry McAuliffe said Thursday.
It’s among several specific investments the state needs to make to create a stronger life sciences industry, McAuliffe said. He was at the THRiVE 2015 conference, which attracted 350 bioscience leaders from across the state, to talk about how to better merge the commonwealth’s strength in big data with its growing biotech industry. The portal was among multiple ideas raised by an eager group of business leaders who sought more support from the state in their efforts to commercialize their work.
George Mason University unveiled its new $40 million Advanced Biomedical Research building Thursday, signaling its expansion in genomics and precision medicine research.
The university simultaneously renamed its Manassas campus its Science and Technology campus.
How much venture capital money is out there for healthcare start-ups?
Apparently, quite a bit.
According to a recent article in the Wall Street Journal, medical start-ups in the United States raised around $3.9 billion in venture capital during the first quarter of this year. Here are eight key trends from the report:
